SCHEMBL3175682

SCHEMBL3175682

CC(=O)NCCNc1cc(NCCNC(=O)CNC(C)=O)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.50
MALT1 Q9UDY8 2/20 0.45
CNR1 P21554 1/20 0.42
LTA4H P09960 1/20 0.42
CYP1A2 P05177 5/20 0.41
ALDH1A1 P00352 5/20 0.41
CYP3A4 P08684 4/20 0.41
HSD17B10 Q99714 3/20 0.41
CLK4 Q9HAZ1 3/20 0.41
ALOX15 P16050 2/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP2D6 P10635 2/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
RECQL P46063 1/20 0.40
HBB P68871 1/20 0.40
GPR119 Q8TDV5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3171606 0.93 ADORA3 (0.46) ADORA3MALT1LTA4HALDH1A1MEN1
SCHEMBL3176983 0.93 ADORA3 (0.57) ADORA3MALT1CNR1LTA4HCYP1A2
SCHEMBL3175971 0.91 ADORA3 (0.56) ADORA3MALT1CNR1LTA4HCYP1A2
SCHEMBL3164769 0.88 GPR139 (0.46) ADORA3CYP1A2ALDH1A1CYP3A4HSD17B10
SCHEMBL3165790 0.88 ADORA1 (0.50) ADORA3CYP1A2ALDH1A1CYP3A4HSD17B10
SCHEMBL3172079 0.87 ADORA3 (0.51) ADORA3MALT1CNR1LTA4HCYP1A2
SCHEMBL3165040 0.86 ADORA3 (0.53) ADORA3MALT1CNR1LTA4HCYP1A2
SCHEMBL3170639 0.85 KMT2A (0.48) ADORA3MALT1CNR1LTA4HCYP1A2
SCHEMBL3163314 0.85 HSD17B10 (0.48) ADORA3CYP1A2ALDH1A1HSD17B10MEN1
SCHEMBL3163677 0.85 ADORA3 (0.49) ADORA3MALT1CNR1LTA4HCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed